Singapore Markets closed

Sabra Health Care REIT, Inc. (SBRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.34+0.04 (+0.35%)
As of 01:31PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 316.60
52-week low 310.08
50-day moving average 312.24
200-day moving average 313.37

Share statistics

Avg vol (3-month) 31.97M
Avg vol (10-day) 32.39M
Shares outstanding 5230.98M
Implied shares outstanding 6N/A
Float 8227.87M
% held by insiders 11.36%
% held by institutions 190.22%
Shares short (12 Jan 2023) 412.05M
Short ratio (12 Jan 2023) 46.45
Short % of float (12 Jan 2023) 47.52%
Short % of shares outstanding (12 Jan 2023) 45.22%
Shares short (prior month 14 Dec 2022) 412.07M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 49.01%
Trailing annual dividend rate 31.35
Trailing annual dividend yield 311.95%
5-year average dividend yield 49.02
Payout ratio 4N/A
Dividend date 327 Feb 2023
Ex-dividend date 409 Feb 2023
Last split factor 21:3
Last split date 315 Nov 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -4.06%
Operating margin (ttm)10.63%

Management effectiveness

Return on assets (ttm)0.46%
Return on equity (ttm)-0.52%

Income statement

Revenue (ttm)419.18M
Revenue per share (ttm)1.82
Quarterly revenue growth (yoy)-52.80%
Gross profit (ttm)246.6M
EBITDA 240.99M
Net income avi to common (ttm)-17.01M
Diluted EPS (ttm)0.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)49.05M
Total cash per share (mrq)0.21
Total debt (mrq)2.45B
Total debt/equity (mrq)76.26
Current ratio (mrq)0.78
Book value per share (mrq)16.19

Cash flow statement

Operating cash flow (ttm)346.08M
Levered free cash flow (ttm)306M